SANUWAVE Health (SNWV) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SANUWAVE Health | 137.37 Mn | 126.59 Mn | 7.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.84% |
| Dec 31, 2025 | 10.15% |
| Sep 30, 2025 | 1.61% |
| Jun 30, 2025 | 57.53% |
| Mar 31, 2025 | 58.17% |
| Dec 31, 2024 | 54.86% |
| Sep 30, 2024 | 67.75% |
| Jun 30, 2024 | 69.25% |
| Mar 31, 2024 | 77.63% |
| Dec 31, 2023 | 80.26% |
| Sep 30, 2023 | 94.89% |
| Jun 30, 2023 | 71.50% |
| Mar 31, 2023 | 80.74% |
| Dec 31, 2022 | 73.10% |
| Sep 30, 2022 | 101.50% |
| Jun 30, 2022 | 95.34% |
| Mar 31, 2022 | 78.01% |
| Dec 31, 2021 | 79.30% |
| Sep 30, 2021 | 76.01% |
| Jun 30, 2021 | 94.13% |
| Mar 31, 2021 | 73.21% |
| Dec 31, 2020 | 88.86% |
| Sep 30, 2020 | 85.39% |
| Jun 30, 2020 | 5.92% |
| Mar 31, 2020 | -2.24% |
| Dec 31, 2019 | -6.24% |
| Sep 30, 2019 | -22.58% |
| Jun 30, 2019 | -27.15% |
| Mar 31, 2019 | -31.21% |
| Dec 31, 2018 | -5.80% |
| Sep 30, 2018 | -16.27% |
| Jun 30, 2018 | -4.40% |
| Mar 31, 2018 | -17.20% |
| Dec 31, 2017 | -7.12% |
| Sep 30, 2017 | -24.36% |
| Jun 30, 2017 | -28.70% |
| Mar 31, 2017 | -26.98% |
| Dec 31, 2016 | -30.43% |
| Sep 30, 2016 | -32.76% |
| Jun 30, 2016 | -41.35% |
| Dec 31, 2015 | -20.56% |